DermBiont
is a Massachusetts-based biotechnology company that researches and develops targeted topical therapeutics for the treatment of skin diseases... Read moreDermBiont
is a Massachusetts-based biotechnology company that researches and develops targeted topical therapeutics for the treatment of skin diseases... Read more
News
Aug 19, 2024
Clinical Trials Arena
DermBiont: DermBiont reports positive data from basal cell carcinoma treatment trial
Feb 21, 2024
Acrofan
DermBiont: DermBiont Announces 2024 Development Pipeline Update for its First-in-Class Targeted Topical Therapeutics for Seborrheic Keratoses, Basal Cell Carcino
May 30, 2023
Business Wire
Press Release: DermBiont : DermBiont Announces Positive Data from a Phase 2 Trial Treating Solar Lentigos and Normalizing Pigmentation of the Skin with 0.8% SM-030 Topical Gel
Mar 22, 2023
Business Wire
Press Release: DermBiont : DermBiont Presents Positive Phase 2 Trial Data Treating Seborrheic Keratosis with SM-020 Topical Gel at American Academy of Dermatology Annual Meeting
Jun 23, 2022
Business Wire
Press Release: DermBiont : DermBiont Announces Positive Phase 2 Clinical Trial Data Treating Seborrheic Keratosis with SM-020, the First and Only Targeted Topical Treatment for these Common Benign Tumors
Jan 15, 2022
sec
DermBiont: DermBiont raised $830.3K in an Equity round
Dec 22, 2021
Endpoints News
DermBiont: Boston startup lands $28M, closes small biotech buyout; New longevity fund takes shape
Dec 21, 2021
FinSMEs
DermBiont: DermBiont Raises $28 Million in Series A2 Funding; Acquires Chromaderm
Dec 21, 2021
Business Wire
Press Release: DermBiont : DermBiont Raises $28 Million and Acquires Chromaderm to Expand Targeted Topical Therapeutics in Development
Mar 03, 2021
The Business Journals: Boston
DermBiont: Boston-based microbiome startup DermBiont raised $6.6M in debt in a $15M funding round, per an SEC filing.
DermBiont Competitors
1
2
3
4
5
6
7